DEF 14C: La Rosa Holdings Corp. Secures $1.25 Million in Financing Through Convertible Note, Shares, and Warrants

Sentiment:

Information Statement


La Rosa Holdings Corp. obtained $1.25 million in funding via a securities purchase agreement involving a convertible note, shares, and warrants, approved by the majority stockholder.

Capital raiseLa Rosa Holdings Corp. entered into a securities purchase agreement with an accredited investor.The company sold a promissory note in the aggregate principal amount of $1,316,000, 50,000 shares of Common Stock, and warrants exercisable for 302,300 shares of Common Stock.The aggregate purchase price was $1,250,200.The company received net proceeds of $1,122,682 after deducting placement agent tail fees and expenses.

Summary

  • La Rosa Holdings Corp. entered into a securities purchase agreement on April 1, 2024, with an accredited investor, resulting in gross proceeds of $1,250,200.
  • The agreement includes the sale of a $1,316,000 promissory note, 50,000 shares of common stock, and warrants for 302,300 shares of common stock.
  • The promissory note bears interest at 13% per annum and matures on April 1, 2025.
  • The note is convertible into common stock at $2.50 per share, subject to adjustments.
  • The company received net proceeds of $1,122,682 after deducting placement agent tail fees and expenses.
  • The majority stockholder, holding approximately 75.4% of the outstanding voting stock, approved the transaction to comply with Nasdaq listing rules.
  • The company intends to use the net proceeds for business development and general working capital purposes.
  • A registration rights agreement requires the company to file a registration statement with the SEC within 90 days of the closing date (June 30, 2024) and have it effective within 120 days (July 30, 2024).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The company secured funding, which is good, but the terms are somewhat expensive and dilutive.

Positives

  • The company successfully raised $1.25 million in gross proceeds to fund business development and working capital.
  • The majority stockholder's approval streamlines the process and ensures compliance with Nasdaq listing rules.
  • The financing provides the company with additional capital without immediate dilution, as the note is convertible and warrants are exercisable in the future.
  • The company retains the option to prepay the note before an event of default.

Negatives

  • The company incurred $127,518 in placement agent tail fees and expenses.
  • The promissory note carries a high interest rate of 13%.
  • The note is secured by all equity and assets of the company and its subsidiaries.
  • The potential conversion of the note and exercise of warrants could dilute existing shareholders.
  • The company is restricted in how it can use the proceeds, limiting its flexibility.

Risks

  • Failure to comply with the registration rights agreement could result in penalties.
  • The conversion of the note at a lower price due to a default could significantly dilute existing shareholders.
  • The company's ability to repay the note depends on its future financial performance.
  • The security agreement grants the investor a priority security interest in the company's assets.
  • The company's stock price could be negatively impacted by the issuance of new shares upon conversion of the note or exercise of the warrants.

Future Outlook

The company intends to use the net proceeds from the financing for business development and general working capital purposes. The company is required to file a registration statement with the SEC to allow the investor to resell the shares of common stock.

Management Comments

  • The Majority Stockholder consent we have received constitutes the only stockholder approval required under the NRS, Nasdaq Listing Rules 5635(b) and 5635(d), our Articles of Incorporation and our Bylaws, to approve the issuance of the Note, Warrants, and Shares, and all of the Common Stock issuable upon conversion of the Note and exercise of the Warrants.
  • Our Board of Directors is not soliciting your consent or your proxy in connection with this action and neither consents nor proxies are being requested from stockholders.

Industry Context

Many small-cap companies listed on the Nasdaq Capital Market utilize similar financing structures, including convertible notes and warrants, to raise capital. This type of financing can be attractive to investors seeking higher returns but also carries risks due to potential dilution and the company's ability to service the debt.

Comparison to Industry Standards

  • The 13% interest rate on the senior secured promissory note is relatively high, reflecting the risk associated with lending to a small-cap company.
  • Comparable companies in the real estate sector, such as Opendoor Technologies and Zillow Group, have also used convertible notes to raise capital, but often at lower interest rates and with different conversion terms.
  • The use of warrants is a common practice in small-cap financings to incentivize investors, but the specific terms, such as the exercise price and cashless exercise provisions, vary widely.
  • The requirement for stockholder approval to comply with Nasdaq listing rules is standard practice for issuances exceeding certain thresholds.

Stakeholder Impact

  • Shareholders may experience dilution if the note is converted and warrants are exercised.
  • The company's employees and customers may benefit from the increased financial stability and business development opportunities resulting from the financing.
  • The company's creditors now have a new senior secured creditor, which could impact their position.
  • The investor benefits from the potential for capital appreciation and interest income.

Next Steps

  • The company must file a preliminary information statement on Schedule 14C with the SEC.
  • The company must file a definitive information statement as soon as permissible.
  • The company must file a registration statement registering for resale by the Investor the shares of Common Stock issued or issuable in the Transaction within 90 days of the Closing Date, or June 30, 2024.
  • The company must have such registration statement effective within 120 days from the Closing Date, or July 30, 2024.

Key Dates

DateDescription
April 1, 2024Record Date for stockholders entitled to receive notice of action by written consent.
April 1, 2024Date of Securities Purchase Agreement, issuance of Note, Shares, and Warrants.
April 1, 2024Closing date of the transaction.
April 1, 2025Maturity date of the promissory note.
June 30, 2024Deadline for filing a registration statement with the SEC.
July 30, 2024Deadline for the registration statement to become effective.
April 18, 2024Date of Information Statement.

Keywords

securities purchase agreement, convertible note, warrants, common stock, financing, Nasdaq listing rules, majority stockholder, registration rights, dilution

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.